The following is a summary of “Discrepancies in Beta-Lactam Antibiotics Cross-Reactivity: Implications for Clinical Practice,” published in the February 2025 issue of European Journal of Allergy and ...
Theriva™ Biologics (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed to treat ...
Qpex presented the results of several clinical trials of xeruborbactam in tandem with established beta-lactam antibiotics at last year’s ID Week Meeting in Washington DC. These will slot into ...
A study of 151 patients with carbapenem-nonsusceptible infections found treatment with imipenem/cilastatin/relebactam was ...
Yesterday during President Donald Trump's first cabinet meeting, Health and Human Services (HHS) Secretary Robert F. Kennedy ...
Sunday Trust on MSN3d
A stellar year for Nigeria's health sectorGovernment must redeem pledge on universal health coverage'. We appreciate the expressed views, but we wish to respectfully lay out the verifiable facts concerning government action in the health ...
Researchers have discovered a novel approach to protecting insulin-producing beta cells from the damaging effects of glucolipotoxicity - a harmful condition linked to the progression of type 2 ...
Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback